NL-OMON43032已完成2 期
A single-center, randomized, open-label, two-arm study to evaluate the ovarian function inhibition of a monophasic combined oral contraceptive (COC) containing 15 mg estetrol (E4) and 3 mg drospirenone (DRSP) and a monophasic COC containing 20 mcg ethinylestradiol (E4)/3 mg drospirenone (Yaz®), administered orally once daily in a 24/4 day regimen for three consecutive cycles - E4/DRSP Ovarian Function Inhibition Study
Estetra SPR0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All inclusion criteria defined in the study protocol (section 3.3.1) must be met for a subject to be eligible for inclusion in the study
排除标准
- •A subject who meets any of the exclusion criteria defined in the study protocol (section 3.3.2) will not be eligible for inclusion in the study:
研究者
相似试验
进行中（未招募）
不适用
A Study to Investigate a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant RecipientsEUCTR2015-003528-29-Outside-EU/EEAovartis Pharma GmbH80
进行中（未招募）
3 期
A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone versus Crinone intravaginal progesterone gel for Luteal Support in In-Vitro Fertilization (LOTUS II)CTRI/2016/01/006490Abbott Laboratories GmbH1,066
进行中（未招募）
1 期
A randomized multicentre study comparing the effectiveness, safety and tolerance of daily oral dygesterone against Crinone gel for use in in-vitro fertilization (IVF)Treatment for the luteal support in in-vitro fertilization (IVF).MedDRA version: 18.1Level: LLTClassification code 10021572Term: In vitro fertilizationSystem Organ Class: 100000004865EUCTR2012-002993-29-BEAbbott Laboratories GmbH1,066
已完成
不适用
A single-center, two-part, randomized, open-label, parallel-group, four-sequence, four-treatment, four-period crossover study to investigate the bioequivalence and the effect of food on the pharmacokinetics and safety of single oral doses of two different formulations of RO6868847 in healthy participantsNL-OMON51381Hoffmann-La Roche48
招募中
1 期
A food effects trial of the pharmacokinetics of brexpiprazole once-weekly (QW) formulation in patients with schizophreniaschizophreniaJPRN-jRCT2071230059Matsumaru Takehisa50